These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36599954)

  • 1. Familial multiple discoid fibromas is linked to a locus on chromosome 5 including the FNIP1 gene.
    van de Beek I; Glykofridis IE; Tanck MWT; Luijten MNH; Starink TM; Balk JA; Johannesma PC; Hennekam E; van den Hoff MJB; Gunst QD; Gille JJP; Polstra AM; Postmus PE; van Steensel MAM; Postma AV; Wolthuis RMF; Menko FH; Houweling AC; Waisfisz Q
    J Hum Genet; 2023 Apr; 68(4):273-279. PubMed ID: 36599954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
    Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
    J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.
    Houweling AC; Gijezen LM; Jonker MA; van Doorn MB; Oldenburg RA; van Spaendonck-Zwarts KY; Leter EM; van Os TA; van Grieken NC; Jaspars EH; de Jong MM; Bongers EM; Johannesma PC; Postmus PE; van Moorselaar RJ; van Waesberghe JH; Starink TM; van Steensel MA; Gille JJ; Menko FH
    Br J Cancer; 2011 Dec; 105(12):1912-9. PubMed ID: 22146830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
    Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
    PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.
    Hasumi H; Baba M; Hasumi Y; Lang M; Huang Y; Oh HF; Matsuo M; Merino MJ; Yao M; Ito Y; Furuya M; Iribe Y; Kodama T; Southon E; Tessarollo L; Nagashima K; Haines DC; Linehan WM; Schmidt LS
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1624-31. PubMed ID: 25775561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birt-Hogg-Dubé syndrome in two Chinese families with mutations in the FLCN gene.
    Hou X; Zhou Y; Peng Y; Qiu R; Xia K; Tang B; Zhuang W; Jiang H
    BMC Med Genet; 2018 Jan; 19(1):14. PubMed ID: 29357828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
    Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O
    Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population.
    Savatt JM; Shimelis H; Moreno-De-Luca A; Strande NT; Oetjens MT; Ledbetter DH; Martin CL; Myers SM; Finucane BM
    Genet Med; 2022 Sep; 24(9):1857-1866. PubMed ID: 35639097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
    Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
    Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birt-Hogg-Dubé Syndrome: A Review of Dermatological Manifestations and Other Symptoms.
    Tong Y; Schneider JA; Coda AB; Hata TR; Cohen PR
    Am J Clin Dermatol; 2018 Feb; 19(1):87-101. PubMed ID: 28695430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
    Schmidt LS; Nickerson ML; Warren MB; Glenn GM; Toro JR; Merino MJ; Turner ML; Choyke PL; Sharma N; Peterson J; Morrison P; Maher ER; Walther MM; Zbar B; Linehan WM
    Am J Hum Genet; 2005 Jun; 76(6):1023-33. PubMed ID: 15852235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are multiple trichodiscomas/fibrofolliculomas the Birt-Hogg-Dubé syndrome?].
    Belousova IE; Shpilyuk RG; Chepushtanova KO; Gorbunov YG; Kazakov DV
    Arkh Patol; 2021; 83(3):45-51. PubMed ID: 34041896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
    Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
    J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families.
    Leter EM; Koopmans AK; Gille JJ; van Os TA; Vittoz GG; David EF; Jaspars EH; Postmus PE; van Moorselaar RJ; Craanen ME; Starink TM; Menko FH
    J Invest Dermatol; 2008 Jan; 128(1):45-9. PubMed ID: 17611575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
    Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
    BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.